Verve Therapeutics

Verve Therapeutics

Boston, Massachusetts
284 Total Employees
Year Founded: 2018

Similar Companies Hiring

Software • Healthtech • Hardware • Analytics
New York, NY
25 Employees
Telehealth • Social Impact • Pharmaceutical • Healthtech
Miami, FL
13 Employees
Software • Pharmaceutical • Logistics • Healthtech
Conshohocken, PA
10000 Employees

Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts


Verve Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
Boston, Massachusetts